BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3474060)

  • 1. Differing patterns of human protooncogene expression in peripheral blood and bone marrow acute leukemia cells.
    Preisler HD; Sato H; Li YQ; Stein G; Stein J
    Cancer Res; 1987 Jul; 47(14):3747-51. PubMed ID: 3474060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission.
    Preisler HD; Kinniburgh AJ; Wei-Dong G; Khan S
    Cancer Res; 1987 Feb; 47(3):874-80. PubMed ID: 2433029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of minimal residual disease in acute myelogenous leukemia by RNA-in situ hybridization.
    Evinger-Hodges MJ; Spinolo JA; Spencer V; Nieto P; Dicke KA
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():13-5. PubMed ID: 2653488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protooncogene expression in subpopulations of cells from leukemia patients.
    Hulette BC; Banavali SD; Finke DP; Gopal V; Preisler HD
    Cytometry; 1992; 13(6):653-8. PubMed ID: 1451597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of growth-regulated genes in human acute leukemias.
    Ferrari S; Narni F; Mars W; Kaczmarek L; Venturelli D; Anderson B; Calabretta B
    Cancer Res; 1986 Oct; 46(10):5162-6. PubMed ID: 3756869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the proto-oncogenes c-sis, c-fos, c-myc and c-myb in acute myeloid leukemias.
    Strassburg CP; Neubauer V; Poliwoda H; Benter T
    Neoplasma; 1992; 39(6):343-7. PubMed ID: 1491723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-fos correlates with IFN-alpha responsiveness in Philadelphia chromosome positive chronic myelogenous leukemia.
    Eibl B; Greiter E; Grünewald K; Gastl G; Weyrer K; Thaler J; Aulitzky W; Herrmann F; Rapp U; Huber C
    Cytokines Mol Ther; 1995 Mar; 1(1):29-38. PubMed ID: 9384661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proto-oncogene expression in human normal bone marrow.
    Evinger-Hodges MJ; Dicke KA; Gutterman JU; Blick M
    Leukemia; 1987 Aug; 1(8):597-602. PubMed ID: 3669772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of growth-regulated protooncogenes in human malignant plasma cells.
    Palumbo AP; Pileri A; Dianzani U; Massaia M; Boccadoro M; Calabretta B
    Cancer Res; 1989 Sep; 49(17):4701-4. PubMed ID: 2667753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human peripheral blood granulocytes and myeloid leukemic cell lines express both transcripts encoding for stem cell factor.
    Ramenghi U; Ruggieri L; Dianzani I; Rosso C; Brizzi MF; Camaschella C; Pietsch T; Saglio G
    Stem Cells; 1994 Sep; 12(5):521-6. PubMed ID: 7528592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia.
    Woźniak J; Kopeć-Szlezak J
    Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing patterns of proto-oncogene expression in immature and mature myeloid cells.
    Preisler HD; Guan WD; Khan S; Kinniburgh A
    Leuk Res; 1987; 11(10):923-34. PubMed ID: 2446085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells.
    Abbaszadegan MR; Futscher BW; Klimecki WT; List A; Dalton WS
    Cancer Res; 1994 Sep; 54(17):4676-9. PubMed ID: 8062263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
    Curran T; Bravo R; Müller R
    Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
    Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
    Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients.
    Dicke KA; Tindle SE; Davis FM; Jagannath S; Tucker S; Lilien M; van Leeuwen P; Verma DS; Vellekoop L
    Exp Hematol; 1983 Apr; 11(4):341-50. PubMed ID: 6341080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of oncogenes in human leukemias.
    McClain KL
    Cancer Res; 1984 Nov; 44(11):5382-9. PubMed ID: 6593118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. myc and sis expression in acute myelogenous leukemia.
    Evinger-Hodges MJ; Bresser J; Brouwer R; Cox I; Spitzer G; Dicke K
    Leukemia; 1988 Jan; 2(1):45-9. PubMed ID: 2448556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood.
    Popova EY; Claxton DF; Lukasova E; Bird PI; Grigoryev SA
    Exp Hematol; 2006 Apr; 34(4):453-62. PubMed ID: 16569592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.